在临床实践中实施心血管预防指南. 来自POLASPIRE II调查的结果
Piotr Jankowski1,2, Dominika Koczwarska-Maciejek1, Karol Kamiński3,4
1Department of Internal Medicine and Geriatric Cardiology, Center of Postgraduate Medical Education, Warszawa, Poland.
Kardiologia polska
|January 2, 2025
概括
冠状动脉疾病患者的心血管风险管理显示有改进的空间. 目前针对高血压和胆固醇等危险因素的指导方针的实施需要在临床实践中得到加强.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
- 临床实践研究 临床实践研究
背景情况:
- 在日常临床实践中对当前指南实施的理解有限.
- 专注于冠状动脉疾病 (CAD) 患者的风险因素管理.
研究的目的:
- 评估心血管预防指南的实施情况.
- 在CAD患者中评估风险因素控制 (生活方式和药物治疗).
主要方法:
- 波兰12个心脏病科的多中心研究 (2022-2023年).
- 采访了801名患者 (≤80岁) 经过急性冠状动脉综合征或再血管化后6-18个月.
主要成果:
- 没有控制的风险因素的高患病率:66.5%高血压,79.8%高LDL胆固醇,16.0%高HbA1c,19.5%吸烟者,80.5%超重/肥胖.
- 药物坚持率高:≥92.8%的抗血小板药物,84.7%的β-抑制剂,79.8%的ACEI/ARB,89.5%的降脂药物.
- 只有8.6%的人能够控制所有5个主要风险因素;2.4%的人通过特定关键药物达到所有目标.
结论:
- 显著的潜力存在于进一步降低波兰CAD患者的心血管风险.
- 建议加强对心血管预防计划的认可和修订.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Pre-Procedural Guidelines for Assessing Blood Pressure
520
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
520
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
465
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
465
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
Assessment of the Cardiovascular System I: Subjective Data
277
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
277
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
147
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147


